Saiki S, Kuroiwa M, Hashimoto K, Nakajima-Yoshida H, et al. LP.8.1-directed recombinant protein COVID-19 vaccine S-268025, formulated with squalene-based adjuvant A-910823, elicits robust immunogenicity and neutralizing breadth in mice. Vaccine 2026;93:129177.
PMID: 42784873